Literature DB >> 16376382

Position preference on glucuronidation of mono-hydroxylflavones in human intestine.

Li Zhang1, Ge Lin, Zhong Zuo.   

Abstract

Extensive intestinal glucuronidation has been previously reported in both human and animals after oral administration of naturally occurred flavonoids. The present study aims to investigate the relationship between human intestinal glucuronidation activity and the position of hydroxyl substitution on flavonoids. Seven commercially available mono-hydroxyflavones (HF), namely 3-, 5-, 6-, 7-, 2'-, 3'- and 4'-mono-hydroxyflavones, were chosen as model compounds. Glucuronidation activity of the selected seven HFs was investigated by incubating each HF at various concentrations with human jejunum S9 at 37 degrees C for 10 min. The generated glucuronides were identified by HPLC/MS and quantified by HPLC/UV. Metabolic kinetics parameters including Km and Vmax of each HF were determined. The results demonstrated that the glucuronidation activity of 6- and 3'-mono-hydroxyflavones was much greater than that of 3-, 4'-, 7- and 2'-HF with 5-HF to be the lowest. The findings imply that nucleophilicity and stereo-conformation of OH substituents are crucial for the intestinal glucuronidation of flavonoids.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16376382     DOI: 10.1016/j.lfs.2005.10.038

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

1.  The silkworm Green b locus encodes a quercetin 5-O-glucosyltransferase that produces green cocoons with UV-shielding properties.

Authors:  Takaaki Daimon; Chikara Hirayama; Masatoshi Kanai; Yoshinao Ruike; Yan Meng; Eiichi Kosegawa; Masatoshi Nakamura; Gozoh Tsujimoto; Susumu Katsuma; Toru Shimada
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-04       Impact factor: 11.205

2.  Use of glucuronidation fingerprinting to describe and predict mono- and dihydroxyflavone metabolism by recombinant UGT isoforms and human intestinal and liver microsomes.

Authors:  Lan Tang; Ling Ye; Rashim Singh; Baojian Wu; Chang Lv; Jie Zhao; Zhongqiu Liu; Ming Hu
Journal:  Mol Pharm       Date:  2010-06-07       Impact factor: 4.939

Review 3.  First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics.

Authors:  Baojian Wu; Kaustubh Kulkarni; Sumit Basu; Shuxing Zhang; Ming Hu
Journal:  J Pharm Sci       Date:  2011-04-11       Impact factor: 3.534

Review 4.  Regioselective sulfation and glucuronidation of phenolics: insights into the structural basis.

Authors:  Baojian Wu; Sumit Basu; Shengnan Meng; Xiaoqiang Wang; Ming Hu
Journal:  Curr Drug Metab       Date:  2011-11       Impact factor: 3.731

5.  Use of isoform-specific UGT metabolism to determine and describe rates and profiles of glucuronidation of wogonin and oroxylin A by human liver and intestinal microsomes.

Authors:  Qiong Zhou; Zhijie Zheng; Bijun Xia; Lan Tang; Chang Lv; Wei Liu; Zhongqiu Liu; Ming Hu
Journal:  Pharm Res       Date:  2010-04-22       Impact factor: 4.200

6.  Metabolite Identification of a Novel Anti-Leishmanial Agent OJT007 in Rat Liver Microsomes Using LC-MS/MS.

Authors:  Maria Eugenia Rincon Nigro; Ting Du; Song Gao; Manvir Kaur; Huan Xie; Omonike Arike Olaleye; Dong Liang
Journal:  Molecules       Date:  2022-04-30       Impact factor: 4.927

7.  Regioselectivity of human UDP-glucuronosyl-transferase 1A1 in the synthesis of flavonoid glucuronides determined by metal complexation and tandem mass spectrometry.

Authors:  Barry D Davis; Jennifer S Brodbelt
Journal:  J Am Soc Mass Spectrom       Date:  2007-11-17       Impact factor: 3.109

8.  Metabolism, oral bioavailability and pharmacokinetics of chemopreventive kaempferol in rats.

Authors:  Avantika Barve; Chi Chen; Vidya Hebbar; Joseph Desiderio; Constance Lay-Lay Saw; Ah-Ng Kong
Journal:  Biopharm Drug Dispos       Date:  2009-10       Impact factor: 1.627

9.  Involvement of UDP-glucuronosyltransferases in the extensive liver and intestinal first-pass metabolism of flavonoid baicalein.

Authors:  Li Zhang; Ge Lin; Zhong Zuo
Journal:  Pharm Res       Date:  2006-11-16       Impact factor: 4.580

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.